{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:26:02Z","timestamp":1792603562919,"version":"4.5.0"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00491","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:32:09Z","timestamp":1539131529000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":131,"title":["A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology"],"prefix":"10.3389","volume":"9","author":[{"given":"Travis A.","family":"Wearne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/02791072.2000.10400221","article-title":"History of the methamphetamine problem","volume":"32","author":"Anglin","year":"2000","journal-title":"J Psychoactive Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/npp.2011.276","article-title":"Is cognitive functioning impaired in methamphetamine users? A critical review","volume":"37","author":"Hart","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10673220591003605","article-title":"Implications of chronic methamphetamine use: a literature review","volume":"13","author":"Meredith","year":"2005","journal-title":"Harv Rev Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/ADT.0b013e318066d5e0","article-title":"An overview of methamphetamine-induced psychotic syndromes","volume":"7","author":"Zorick","year":"2008","journal-title":"Addict Disord Their Treatm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1037\/0033-2909.134.2.301","article-title":"Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications","volume":"134","author":"Homer","year":"2008","journal-title":"Psychol Bull."},{"key":"B6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0014-2999(82)90103-0","article-title":"Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine","volume":"81","author":"Chuang","year":"1982","journal-title":"Euro J Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-90-481-2448-0","article-title":"Pharmacology of methamphetamine","volume-title":"Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs","author":"Freye","year":"2010"},{"key":"B9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2006.08.031","article-title":"Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats","volume":"549","author":"Izawa","year":"2006","journal-title":"Eur J Pharmacol."},{"key":"B10","volume-title":"Methamphetamine: Its History, Pharmacology and Treatment","author":"Weisheit","year":"2013"},{"key":"B11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.coph.2004.09.005","article-title":"Psychostimulants and monoamine transporters: upsetting the balance","volume":"5","author":"Elliott","year":"2005","journal-title":"Curr Opin Pharmacol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res Brain Res Rev."},{"key":"B13","volume-title":"World Drug Report","year":"2009"},{"key":"B14","volume-title":"Global Amphetamine-type Stimulant Assessment: Amphetamine and Ecstasy.","year":"2011"},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","article-title":"Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study","volume":"70","author":"McKetin","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B16","volume-title":"World Drug Report","year":"2013"},{"key":"B17","volume-title":"World Drug Report","year":"2014"},{"key":"B18","volume-title":"World Drug Report","year":"2003"},{"key":"B19","volume-title":"Global Synthetic Drugs Assessment: Amphetamine-Type Stimulants and New Psychoactive Substances","year":"2014"},{"key":"B20","volume-title":"National Admissions to Substance Abuse Treatment Service, Treatment Episode Data Set (TEDS): 1994-2004.","year":"2006"},{"key":"B21","volume-title":"Reults from the 2007 National Survey on Drug Use and Health: National Findings","year":"2008"},{"key":"B22","first-page":"16","year":"2016","journal-title":"Treatment Episode Data Set (TEDS): 2004\u20132014. National Admissions to Substance Abuse Treatment Services. No. BHSIS Series S-84, HHS Publication No."},{"key":"B23","volume-title":"Alcohol and Other Drug Treatment Services in Australia 2014-15.","year":"2016"},{"key":"B24","volume-title":"National Hospital Morbidity Database: Principal Diagnosis Data Cubes for 1993-94 to 2012-13","year":"2016"},{"key":"B25","volume-title":"Queensland Methamphetamine Paper","year":"2017"},{"key":"B26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0090-9556(25)07478-1","article-title":"Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride","volume":"21","author":"Cook","year":"1993","journal-title":"Drug Metab Disposition"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"B28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/0959523021000023199","article-title":"The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system","volume":"21","author":"Topp","year":"2002","journal-title":"Drug Alcohol Rev."},{"key":"B29","volume-title":"National Drug Strategy Household Survey Report.","year":"2010"},{"key":"B30","volume-title":"National Drug Strategy Household Survey Report.","year":"2013"},{"key":"B31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1471-244X-12-221","article-title":"Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?","volume":"12","author":"Bramness","year":"2012","journal-title":"BMC Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","article-title":"The prevalence of psychotic symptoms among methamphetamine users","volume":"101","author":"McKetin","year":"2006","journal-title":"Addiction"},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am J Addict."},{"key":"B34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb25965.x","article-title":"A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis","volume":"654","author":"Sato","year":"1992","journal-title":"Ann N Y Acad Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1196\/annals.1316.035","article-title":"Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis","volume":"1025","author":"Ujike","year":"2004","journal-title":"Ann N Y Acad Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.psychres.2013.06.030","article-title":"Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure","volume":"210","author":"Salo","year":"2013","journal-title":"Psychiatry Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.psychres.2018.05.033","article-title":"The prevalence of substance-induced psychotic disorder in methamphetamine misusers: a meta-analysis","volume":"268","author":"Lecomte","year":"2018","journal-title":"Psychiatry Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.genm.2010.09.003","article-title":"Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants","volume":"7","author":"Mahoney","year":"2010","journal-title":"Gend Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1465-3362.2009.00160.x","article-title":"The risk of psychotic symptoms associated with recreational methamphetamine use","volume":"29","author":"McKetin","year":"2010","journal-title":"Drug Alcohol Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S0033291703008353","article-title":"Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis","volume":"33","author":"Chen","year":"2003","journal-title":"Psychol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drugalcdep.2006.04.007","article-title":"The relationship between crystalline methamphetamine use and methamphetamine dependence","volume":"85","author":"McKetin","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"B42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1360-0443.2002.00143.x","article-title":"Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration","volume":"97","author":"Matsumoto","year":"2002","journal-title":"Addiction"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drugpo.2016.10.018","article-title":"Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: evidence from a high-risk population","volume":"38","author":"Lappin","year":"2016","journal-title":"Int J Drug Policy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1192\/bjp.181.5.393","article-title":"Psychosis and drug dependence: results from a national survey of prisoners","volume":"181","author":"Farrell","year":"2002","journal-title":"Br J Psychiatry"},{"key":"B45","volume-title":"Estimating the Number of Regular and Dependent Methamphetamine Users in Australia","author":"McKetin","year":"2005"},{"key":"B46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dar.12426","article-title":"Crystalline methamphetamine use and methamphetamine-related harms in Australia","volume":"36","author":"Degenhardt","year":"2017","journal-title":"Drug Alcohol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4050932","DOI":"10.1155\/2017\/4050932","article-title":"Methamphetamine use and emergency department utilization: 20 years later","volume":"2017","author":"Richards","year":"2017","journal-title":"J Addict."},{"key":"B48","first-page":"347","article-title":"Methamphetamine Intoxication in Emergency Departments of Hospitals in Iran: implications for treatment","volume":"38","author":"Alam Mehrjerdi","year":"2013","journal-title":"Iran J Med Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3969\/j.issn.1002-0829.2012.05.004","article-title":"Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use","volume":"24","author":"Deng","year":"2012","journal-title":"Shang Archiv Psychiatry"},{"key":"B50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0447.1994.tb01541.x","article-title":"Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan","volume":"89","author":"Iwanami","year":"1994","journal-title":"Acta Psychiatr Scand."},{"key":"B51","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1360-0443.1989.tb03941.x","article-title":"Methamphetamine psychosis in Japan: a survey","volume":"84","author":"Nakatani","year":"1989","journal-title":"Br J Addict."},{"key":"B52","first-page":"597","article-title":"[Prognostic and criminological studies on the mental disorder caused by the chronic methamphetamine intoxication]","volume":"69","author":"Teraoka","year":"1967","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"B53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1465-3362.2009.00081.x","article-title":"Psychopathology in methamphetamine-dependent adults 3 years after treatment","volume":"29","author":"Glasner-Edwards","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1176\/appi.ajp.2009.08111695","article-title":"Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature","volume":"167","author":"Grelotti","year":"2010","journal-title":"Am J Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/0004867417748750","article-title":"A systematic review of risk factors for methamphetamine-associated psychosis","volume":"52","author":"Arunogiri","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"key":"B56","first-page":"15","article-title":"Methamphetamine-induced psychosis: who says all drug use is reversible?","volume":"16","author":"Cadet","year":"2018","journal-title":"Curr. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40263-014-0209-8","article-title":"Methamphetamine psychosis: epidemiology and management","volume":"28","author":"Glasner-Edwards","year":"2014","journal-title":"CNS Drugs"},{"key":"B58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","article-title":"Methamphetamine-associated psychosis","volume":"7","author":"Grant","year":"2012","journal-title":"J Neuroimmune Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/add.14170","article-title":"Methamphetamine psychosis: insights from the past","volume":"113","author":"McKetin","year":"2018","journal-title":"Addiction"},{"key":"B60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1039856217695702","article-title":"Methamphetamine and psychiatry: a story of the colourless substance of abuse","volume":"25","author":"Suetani","year":"2017","journal-title":"Aus Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/j.2051-5545.2008.tb00142.x","article-title":"Should cognitive impairment be included in the diagnostic criteria for schizophrenia?","volume":"7","author":"Keefe","year":"2008","journal-title":"World Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/schbul\/sbj013","article-title":"The structure of negative symptoms within schizophrenia: implications for assessment","volume":"32","author":"Blanchard","year":"2006","journal-title":"Schizophrenia Bull."},{"key":"B63","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jpsychires.2013.01.024","article-title":"Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts","volume":"47","author":"Liemburg","year":"2013","journal-title":"J Psychiatric Res."},{"key":"B64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archpsyc.1991.01810270051007","article-title":"National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome","volume":"48","author":"Breier","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, (DSM-5\u00ae).","author":"Association","year":"2013"},{"key":"B66","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.156.9.1358","article-title":"Memory impairment in schizophrenia: a meta-analysis","volume":"156","author":"Aleman","year":"1999","journal-title":"Am J Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevNeurobiol.v14.i1.10","article-title":"Cognitive impairment in schizophrenia is the core of the disorder","volume":"14","author":"Elvevag","year":"2000","journal-title":"Crit Rev Neurobiol."},{"key":"B68","first-page":"245","article-title":"Neurocognitive functioning in patients with schizophrenia: an overview","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"Goldberg","year":"1995"},{"key":"B69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophrenia Res."},{"key":"B70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","article-title":"Neurocognitive deficit in schizophrenia: a quantitative review of the evidence","volume":"12","author":"Heinrichs","year":"1998","journal-title":"Neuropsychology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/archpsyc.57.9.907","article-title":"Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect","volume":"57","author":"Weickert","year":"2000","journal-title":"Archiv Gen Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00048674.2010.541418","article-title":"Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature","volume":"45","author":"Bozikas","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/13803395.2011.578569","article-title":"Cognitive profiles in persons with chronic schizophrenia","volume":"33","author":"Dawes","year":"2011","journal-title":"J Clin Exper Neuropsychol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/S0033291710001042","article-title":"Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder","volume":"41","author":"Lewandowski","year":"2011","journal-title":"Psychol Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.bp.106.029009","article-title":"Longitudinal studies of cognition in schizophrenia: meta-analysis","volume":"192","author":"Sz\u00f6ke","year":"2008","journal-title":"Br J Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fnhum.2013.00643","article-title":"Ten year neurocognitive trajectories in first-episode psychosis","volume":"7","author":"Barder","year":"2013","journal-title":"Front Hum Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"key":"B78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archpsyc.1994.03950020048005","article-title":"Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia","volume":"51","author":"Saykin","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/schbul\/sbn127","article-title":"Neurocognitive decline in early-onset Schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study","volume":"36","author":"\u00d8ie","year":"2010","journal-title":"Schizophr Bull."},{"key":"B80","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pbb.2010.11.009","article-title":"The treatment of cognitive impairment in schizophrenia","volume":"99","author":"Goff","year":"2011","journal-title":"Pharmacol Biochem Behav."},{"key":"B81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0033291797006041","article-title":"Executive function in first-episode schizophrenia","volume":"28","author":"Hutton","year":"1998","journal-title":"Psychol Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/archgenpsychiatry.2009.91","article-title":"Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia","volume":"66","author":"Minzenberg","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12888-016-0749-1","article-title":"Cognitive impairment in schizophrenia across age groups: a case\u2013control study","volume":"16","author":"Mosio\u0142ek","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.schres.2009.09.025","article-title":"Executive function in schizophrenia: influence of substance use disorder history","volume":"118","author":"Rodriguez-Jimenez","year":"2010","journal-title":"Schizophr Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1176\/appi.ajp.162.3.495","article-title":"Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up","volume":"162","author":"Milev","year":"2005","journal-title":"Am J Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0193-953X(02)00084-9","article-title":"Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment","volume":"26","author":"Sharma","year":"2003","journal-title":"Psychiatr Clin North Am."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/gerona\/61.12.1330","article-title":"Cognitive domains and trajectories of functional independence in nondemented elderly persons","volume":"61","author":"Dodge","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0003-9993(97)90085-X","article-title":"Home alone: the role of cognition in return to independent living","volume":"78","author":"MacNeill","year":"1997","journal-title":"Archiv Phys Med Rehabilit."},{"key":"B89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1399-5618.2007.00427.x","article-title":"Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder","volume":"9","author":"Jaeger","year":"2007","journal-title":"Bipolar Disord."},{"key":"B90","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4065\/77.7.681","article-title":"Achieving and maintaining cognitive vitality with aging","volume":"77","author":"Fillit","year":"2002","journal-title":"Mayo Clin Proc."},{"key":"B91","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1465-3362.2010.00196.x","article-title":"Long-term outcomes in methamphetamine psychosis patients after first hospitalisation","volume":"29","author":"Kittirattanapaiboon","year":"2010","journal-title":"Drug Alcohol Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1017\/s0033291717001118","article-title":"Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study","volume":"47","author":"Alderson","year":"2017","journal-title":"Psychol Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.4088\/JCP.12m07822","article-title":"Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases","volume":"74","author":"Niemi-Pynttari","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1176\/appi.ajp.2011.10070937","article-title":"Methamphetamine use and schizophrenia: a population-based cohort study in California","volume":"169","author":"Callaghan","year":"2012","journal-title":"Am J Psychiatry"},{"key":"B95","volume-title":"Amphetamine Psychosis","author":"Connell","year":"1958"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ajmg.b.30936","article-title":"Genetic association studies of methamphetamine use disorders: A systematic review and synthesis","author":"Bousman","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/npp.2013.94","article-title":"Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia","volume":"38","author":"Ikeda","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajmg.b.30187","article-title":"Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis","author":"Chen","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B99","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/ajp.153.6.812","article-title":"When does amphetamine-induced psychosis become schizophrenia?","volume":"153","author":"Flaum","year":"1996","journal-title":"Am J Psychiatry"},{"key":"B100","first-page":"388","article-title":"Six months follow-up of patients with methamphetamine psychosis","volume":"64","author":"Yeh","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B101","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0376-8716(99)00060-5","article-title":"Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress","volume":"58","author":"Yui","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"B102","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1176\/jnp.15.3.317","article-title":"Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review","volume":"15","author":"Nordahl","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict Behav."},{"key":"B104","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol Rev."},{"key":"B105","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2014.12.035","article-title":"Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users","volume":"148","author":"Chen","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B106","first-page":"152","article-title":"Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects","volume":"9","author":"Ezzatpanah","year":"2014","journal-title":"Iran J Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psychres.2014.11.077","article-title":"Primary and substance-induced psychotic disorders in methamphetamine users","volume":"226","author":"Hides","year":"2015","journal-title":"Psychiatry Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/WNN.0b013e31816bdf90","article-title":"An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia","volume":"21","author":"Jacobs","year":"2008","journal-title":"Cogn Behav Neurol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.psychres.2017.02.028","article-title":"Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders","volume":"251","author":"McKetin","year":"2017","journal-title":"Psychiatry Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.psychres.2012.09.023","article-title":"A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards","volume":"206","author":"Medhus","year":"2013","journal-title":"Psychiatry Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/adb.12224","article-title":"Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study","volume":"21","author":"Okada","year":"2016","journal-title":"Addic. Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000452476","article-title":"First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia","volume":"49","author":"Shelly","year":"2016","journal-title":"Psychopathology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.pnpbp.2011.01.014","article-title":"Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis","volume":"35","author":"Srisurapanont","year":"2011","journal-title":"Progr Neuro Psychopharmacol Biol Psychiatry"},{"key":"B114","first-page":"531","article-title":"Chronic schizophrenia-like states in methamphetamine psychosis","volume":"44","author":"Tomiyama","year":"1990","journal-title":"Jpn J Psychiatry Neurol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000445065","article-title":"Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia","volume":"49","author":"Wang","year":"2016","journal-title":"Psychopathology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"12107","DOI":"10.1038\/srep12107","article-title":"Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia","volume":"5","author":"Yamamuro","year":"2015","journal-title":"Sci Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/eip.12404","article-title":"Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders","volume":"12","author":"Hajebi","year":"2018","journal-title":"Early Interv Psychiatry"},{"key":"B118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00005053-196704000-00005","article-title":"Amphetamine psychosis: I. Description of the individuals and process","volume":"144","year":"1967","journal-title":"J Nerv Ment Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/ajad.12160","article-title":"Typologies of positive psychotic symptoms in methamphetamine dependence","volume":"24","author":"Bousman","year":"2015","journal-title":"Am J Addict."},{"key":"B120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/09638237.2012.745184","article-title":"Clinical features of inpatients with methamphetamine-induced psychosis","volume":"22","author":"Fasihpour","year":"2013","journal-title":"J Ment Health"},{"key":"B121","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","article-title":"The profile of psychiatric symptoms exacerbated by methamphetamine use","volume":"161","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B122","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S1461145703003675","article-title":"Psychotic symptoms in methamphetamine psychotic in-patients","volume":"6","author":"Srisurapanont","year":"2003","journal-title":"Int J Neuropsychopharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632-2000.tb05178.x","article-title":"Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia","volume":"914","author":"Yui","year":"2000","journal-title":"Ann N Y Acad Sci."},{"key":"B124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-3956(74)90064-8","article-title":"Amphetamine psychosis: behavioral and biochemical aspects","volume":"11","author":"Angrist","year":"1974","journal-title":"J Psychiatr Res."},{"key":"B125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1192\/bjp.111.477.701","article-title":"Comparison of amphetamine psychosis and schizophrenia","volume":"111","author":"Bell","year":"1965","journal-title":"Br J Psychiatry"},{"key":"B126","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1440-1665.2006.02252.x","article-title":"Drug-induced psychosis associated with crystalline methamphetamine","volume":"14","author":"Dore","year":"2006","journal-title":"Aus Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1749-6632.2002.tb04171.x","article-title":"Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis","volume":"965","author":"Yui","year":"2002","journal-title":"Ann N Y Acad Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1196\/annals.1369.012","article-title":"Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence","volume":"1074","author":"Akiyama","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0447.1990.tb01350.x","article-title":"Hallucinations in schizophrenia","volume":"82","author":"Mueser","year":"1990","journal-title":"Acta Psychiatr Scand."},{"key":"B130","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1093\/schbul\/sbu036","article-title":"Visual Hallucinations in the Psychosis Spectrum and Comparative Information From Neurodegenerative Disorders and Eye Disease","volume":"40","author":"Waters","year":"2014","journal-title":"Schizophrenia Bull."},{"key":"B131","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.psc.2013.02.005","article-title":"Neurologic manifestations of chronic methamphetamine abuse","volume":"36","author":"Rusyniak","year":"2013","journal-title":"Psychiatric Clinics"},{"key":"B132","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/ADT.0b013e3181cf58f2","article-title":"Methamphetamine Psychosis in Australia, Philippines, and Thailand: recommendations for acute care and clinical inpatient management","volume":"9","author":"Ali","year":"2010","journal-title":"Addict Disord Their Treatm."},{"key":"B133","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.euroneuro.2013.10.017","article-title":"Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders","volume":"24","author":"Foussias","year":"2014","journal-title":"Euro Neuropsychopharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.eurpsy.2007.03.010","article-title":"Clinical evaluation of negative symptoms in schizophrenia","volume":"22","author":"M\u00f6ller","year":"2007","journal-title":"Euro Psychiatry"},{"key":"B135","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2010.02.1030","article-title":"Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort","volume":"119","author":"Bobes","year":"2010","journal-title":"Schizophrenia Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/08039480801959307","article-title":"Negative symptoms in schizophrenia\u2014A review","volume":"62","author":"Makinen","year":"2008","journal-title":"Nordic J Psychiatry"},{"key":"B137","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1152\/jn.1981.46.4.755","article-title":"Behavioral enhancement of visual responses in monkey cerebral cortex. I Modulation in posterior parietal cortex related to selective visual attention","volume":"46","author":"Bushnell","year":"1981","journal-title":"J Neurophysiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1521-0391.2011.00124.x","article-title":"Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients","volume":"20","author":"Akiyama","year":"2011","journal-title":"Am J Addict."},{"key":"B139","volume-title":"Amphetamine Related Psychiatric Disorders","author":"Mullen","year":"2018"},{"key":"B140","doi-asserted-by":"publisher","first-page":"s10","DOI":"10.3109\/00952990.2013.861843","article-title":"Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis","volume":"40","author":"Farnia","year":"2014","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:13:52Z","timestamp":1775243632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":140,"alternative-id":["10.3389\/fpsyt.2018.00491"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00491","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"article-number":"491"}}